Want to track NRXP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NRx Pharmaceuticals, Inc. (NRXP) Statistics
Valuation metrics
Market Cap 59.98M
Enterprise value 34.89M
Trailing P/E (ttm) -4.7
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) 17.77
Price/Book (mrq) -772.92
Enterprise Value/Revenue 10.28
Enterprise Value/EBITDA -1.59
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 522.56K
Average volume (90 days) 662.93K
Price summary
52-Week low 1.62
52-Week high 5.05
Beta -
50-Day moving average 3.6
200-Day moving average 2.66
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 2 Apr 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.92%
Operating margin -5.88%
Operational effectiveness
Return on assets -0.69%
Return on equity 1.69%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.09
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.62
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.71
Total debt (mrq) -
Total Debt/Equity (mrq) -7.33
Current ratio (mrq) 0.86%
Book value per share (mrq) -0
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
